CompletedNCT00190957
Atomoxetine for adults with ADHD and alcohol use
About this title
Read the official source — NCT00190957Medication studyAges 18+United States + Canada
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- El Centro and 14 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 140
- Sponsor
- Eli Lilly and Company
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States, Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00190957
- Official title
Show the full official title
Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
El Centro, United States · Poway, United States · San Diego, United States
12 more locations
- New London, United States
- Orlando, United States
- Cambridge, United States
- Okemos, United States
- Columbia, United States
- Moorestown, United States
- New York, United States
- Charleston, United States
- Herndon, United States
- Seattle, United States
- Middleton, United States
- Vancouver, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Eli Lilly and Company.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine and placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.
